Windlas Biotech Limited (WINDLAS) — Strategic Asset Allocation Index
Windlas Biotech Limited (WINDLAS) has a Strategic Asset Allocation Index of 25.0% as of September 2022. Strategic assets (PP&E of Rs1.02 Billion plus long-term investments of Rs-) total Rs1.02 Billion, measured against net assets of Rs4.08 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Windlas Biotech Limited Strategic Asset Allocation Index (2018–2022)
This chart shows how Windlas Biotech Limited's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2022, the index stands at 25.0%, representing strategic assets of Rs1.02 Billion against net assets of Rs4.08 Billion INR. Explore WINDLAS cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Windlas Biotech Limited (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Windlas Biotech Limited from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see WINDLAS company net worth.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 24.9% | Rs983.15 Million | Rs983.15 Million | Rs- | Rs3.95 Billion | ▼ -23.1 pp |
| 2021 | 48.0% | Rs954.95 Million | Rs954.95 Million | Rs- | Rs1.99 Billion | ▲ +14.7 pp |
| 2020 | 33.2% | Rs697.10 Million | Rs697.10 Million | Rs- | Rs2.10 Billion | ▼ -2.1 pp |
| 2019 | 35.3% | Rs683.98 Million | Rs683.98 Million | Rs- | Rs1.94 Billion | ▼ -39.5 pp |
| 2018 | 74.8% | Rs935.59 Million | Rs935.59 Million | Rs- | Rs1.25 Billion | — |